CalciMedica, Inc. (CALC)
CALC Stock Price Chart
Explore CalciMedica, Inc. interactive price chart. Choose custom timeframes to analyze CALC price movements and trends.
CALC Company Profile
Discover essential business fundamentals and corporate details for CalciMedica, Inc. (CALC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Jun 2023
Employees
14.00
Website
https://www.calcimedica.comCEO
A. Rachel Leheny
Description
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
CALC Financial Timeline
Browse a chronological timeline of CalciMedica, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.41.
Earnings released on 12 Aug 2025
EPS came in at -$0.40 matching the estimated -$0.40.
Earnings released on 14 May 2025
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%.
Earnings released on 27 Mar 2025
EPS came in at -$0.34 surpassing the estimated -$0.48 by +29.17%.
Earnings released on 13 Nov 2024
EPS came in at -$0.50 surpassing the estimated -$0.61 by +18.03%.
Earnings released on 12 Aug 2024
EPS came in at -$0.52 surpassing the estimated -$0.55 by +5.45%.
Earnings released on 13 May 2024
EPS came in at -$0.43 surpassing the estimated -$0.50 by +14.00%.
Earnings released on 28 Mar 2024
EPS came in at -$0.23 surpassing the estimated -$1.00 by +77.00%.
Earnings released on 9 Nov 2023
EPS came in at -$0.82 surpassing the estimated -$1.14 by +28.07%.
Earnings released on 10 Aug 2023
EPS came in at -$1.11 falling short of the estimated -$1.02 by -8.82%.
Earnings released on 12 May 2023
EPS came in at -$23.43 falling short of the estimated -$0.73 by -3.11K%.
Stock split effective on 20 Mar 2023
Shares were split 1 : 14 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Mar 2023
EPS came in at -$4.79 surpassing the estimated -$5.88 by +18.50%.
Earnings released on 10 Nov 2022
EPS came in at -$6.44 falling short of the estimated -$6.16 by -4.55%.
Earnings released on 11 Aug 2022
EPS came in at -$5.32 surpassing the estimated -$5.63 by +5.51%.
Earnings released on 10 May 2022
EPS came in at -$6.72 falling short of the estimated -$5.35 by -25.61%.
Earnings released on 10 Mar 2022
EPS came in at -$5.74 falling short of the estimated -$5.12 by -12.11%.
Earnings released on 11 Nov 2021
EPS came in at -$5.32 falling short of the estimated -$5.18 by -2.70%.
Earnings released on 11 Aug 2021
EPS came in at -$5.04 surpassing the estimated -$6.55 by +23.05%.
Earnings released on 12 May 2021
EPS came in at -$7.56 falling short of the estimated -$6.16 by -22.73%.
Earnings released on 4 Mar 2021
EPS came in at -$1.38 falling short of the estimated -$0.40 by -245.00%.
Earnings released on 12 Nov 2020
EPS came in at -$2.52 falling short of the estimated -$0.56 by -350.00%.
Earnings released on 25 Sept 2020
EPS came in at -$7.54 .
CALC Stock Performance
Access detailed CALC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.